ResultsIQ

ResultsIQ › Latest results › Shree Ganesh Remedies Limited

Shree Ganesh Remedies Limited Q4 FY25 results deck summary

NSE: SGRL · BSE: 540737

Results deck of 19 May 2025, summarised by AI from the filing.

FY25 revenue ₹108.60 cr (-14%) on European slowdown and 25-30% realisation fall; margin normalisation expected in coming quarters.

Key takeaways

  1. FY25 revenue Revenue from operations ₹108.60 cr (FY24: ₹125.90 cr, -14%) due to European slowdown and 25-30% realisation fall
  2. Margin outlook Management anticipates margin normalisation in coming quarters and compression in near term
  3. PAT decline FY25 PAT ₹23.10 cr (FY24: ₹28.12 cr, -18%) due to higher depreciation and finance costs from plant 8

Original filing on BSE

Shree Ganesh Remedies Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.